Two monoclonal antibodies which recognized rhPL, placental-derived hPL, and hPL produced by overexpressing cells, failed to detect the protein in unmodified breast cancer cells, in choriocarcinoma cells or in primary breast carcinomas. This evidence concerns the gene LGALS1 and breast carcinoma.